Skip to main content

Table 2 Comparison between patients with and without EV

From: Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease

Characteristic EV (+) (n = 39) EV (−) (n = 191) P value
Age (years) 61 (13–90) 63 (10–87) 0.553
Male gender 25 (64) 88 (46) 0.040
Body mass index (kg/m2) 24.5 (17.3–41.1) 22.7 (11.9–41.0) 0.037
Etiology    
 NAFLD/NASH 7 (18) 50 (26) 0.378
 HBV 10 (26) 37 (19) 0.377
 PBC 5 (13) 37 (19) 0.461
 ALD 10 (26) 13 (7) 0.001
 AIH 0 (0) 15 (8) 0.146
 Other 7 (18) 39 (20) 0.895
Platelet count (×109/l) 99 (34–683) 197 (14–713) 0.013
AST (IU/l) 33 (15–146) 29 (6–1261) 0.194
ALT (IU/l) 25 (8–123) 28 (6–1246) 0.196
Albumin (g/dl) 3.7 (2.7–4.6) 4.2 (1.4–4.9) 0.005
T.Bil (mg/dl) 1.2 (0.4–7.5) 0.7 (0.2–24.2) <0.001
PT% 74 (27–95) 95 (24–128) <0.001
LS (kPa) 10.0 (3.5–75.0) 5.3 (1.5–75.0) <0.001
Spleen size (cm) 11.4 (6.1–24.0) 8.6 (3.9–14.8) <0.001
LSPS 1.7 (0.1–20.0) 0.2 (0.0–6.4) <0.001
APRI 1.4 (0.1–4.8) 0.5 (0.1–33.7) <0.001
FIB-4 5.7 (0.2–12.0) 1.8 (0.1–25.5) <0.001
Platelet-to-spleen ratio 770 (220–5991) 2201 (166–7809) <0.001
  1. Values are expressed as median (range, minimum–maximum) or n (%)